Page last updated: 2024-12-06

echinocystic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Echinocystic acid is a triterpenoid saponin found in various plant species, including *Acanthopanax senticosus*. It has shown potential in numerous pharmacological activities, including anti-inflammatory, anticancer, and antiviral effects. Research suggests it may modulate immune responses, inhibit tumor growth, and possess anti-diabetic properties. Its biosynthesis involves complex metabolic pathways within the plant, starting with the cyclization of squalene. Echinocystic acid is being actively studied for its potential as a therapeutic agent, with ongoing research exploring its mechanisms of action and clinical applications.'

echinocystic acid: aglycone moiety of saponin chrysantellin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID73309
CHEMBL ID230128
CHEBI ID4747
SCHEMBL ID42864
MeSH IDM0079739
PubMed CID6708654
MeSH IDM0079739

Synonyms (41)

Synonym
(3.beta.,16.alpha.)-3,16-dihydroxyolean-12-en-28-oic acid
C08942
510-30-5
CHEMBL230128 ,
chebi:4747 ,
S3837
einecs 208-112-3
unii-l4duw10yof
l4duw10yof ,
olean-12-en-28-oic acid, 3,16-dihydroxy-, (3.beta.,16.alpha.)-
olean-12-en-28-oic acid, 3.beta.,16.alpha.-dihydroxy-
SCHEMBL42864
echinocystic-acid
mfcd00017295
3,16-dihydroxyolean-12-en-28-oic acid
CS-5397
HY-N0271
albizziagenin
echinocystic acid, >=95%
AKOS032962084
(4ar,5r,6as,6br,8ar,10s,12ar,12br,14bs)-5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
Q27106464
bdbm50235152
DTXSID70965278
CCG-269473
Z3251707616
DIVK1C_006447
KBIO1_001391
SPECTRUM4_001640
SPECTRUM_001599
SPECTRUM5_000459
echinocystic acid
KBIOGR_002079
KBIO2_007215
KBIOSS_002079
KBIO2_002079
KBIO2_004647
SPECPLUS_000351
SPECTRUM1800123
(4ar,5s,6as,6br,10s,12ar)-5,10-dihydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid
CCG-39762

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" Lancemaside A has a low bioavailability (1."( Murine metabolism and absorption of lancemaside A, an active compound in the roots of Codonopsis lanceolata.
Hayama, M; Ichikawa, M; Kodera, Y; Komoto, N; Kuroyanagi, M; Nakano, D; Nishihama, T; Ohta, S; Sekita, S; Shirota, O; Ushijima, M, 2010
)
0.36
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
triterpenoidAny terpenoid derived from a triterpene. The term includes compounds in which the C30 skeleton of the parent triterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Tissue factorHomo sapiens (human)IC50 (µMol)0.00010.00010.734410.0000AID1436859
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)IC50 (µMol)40.00000.10003.38006.6000AID1873015
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (26)

Processvia Protein(s)Taxonomy
positive regulation of gene expressionTissue factorHomo sapiens (human)
positive regulation of interleukin-8 productionTissue factorHomo sapiens (human)
positive regulation of endothelial cell proliferationTissue factorHomo sapiens (human)
activation of plasma proteins involved in acute inflammatory responseTissue factorHomo sapiens (human)
activation of blood coagulation via clotting cascadeTissue factorHomo sapiens (human)
activation of cysteine-type endopeptidase activity involved in apoptotic processTissue factorHomo sapiens (human)
blood coagulationTissue factorHomo sapiens (human)
positive regulation of platelet-derived growth factor receptor signaling pathwayTissue factorHomo sapiens (human)
protein processingTissue factorHomo sapiens (human)
positive regulation of cell migrationTissue factorHomo sapiens (human)
positive regulation of TOR signalingTissue factorHomo sapiens (human)
positive regulation of angiogenesisTissue factorHomo sapiens (human)
positive regulation of positive chemotaxisTissue factorHomo sapiens (human)
cytokine-mediated signaling pathwayTissue factorHomo sapiens (human)
protein deacetylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein deacetylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrion organizationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
regulation of ketone biosynthetic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
negative regulation of cardiac muscle cell apoptotic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
response to nutrient levelsNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein demalonylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
peptidyl-lysine demalonylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein desuccinylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
peptidyl-lysine desuccinylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein deglutarylationNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
negative regulation of reactive oxygen species metabolic processNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
epigenetic regulation of gene expressionNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
serine-type endopeptidase activityTissue factorHomo sapiens (human)
protease bindingTissue factorHomo sapiens (human)
protein bindingTissue factorHomo sapiens (human)
phospholipid bindingTissue factorHomo sapiens (human)
cytokine receptor activityTissue factorHomo sapiens (human)
NAD+ ADP-ribosyltransferase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD+-protein ADP-ribosyltransferase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
zinc ion bindingNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD-dependent protein lysine deacetylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-malonyllysine demalonylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-succinyllysine desuccinylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
protein-glutaryllysine deglutarylase activityNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
NAD+ bindingNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (12)

Processvia Protein(s)Taxonomy
extracellular spaceTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
external side of plasma membraneTissue factorHomo sapiens (human)
cell surfaceTissue factorHomo sapiens (human)
membraneTissue factorHomo sapiens (human)
collagen-containing extracellular matrixTissue factorHomo sapiens (human)
serine-type peptidase complexTissue factorHomo sapiens (human)
plasma membraneTissue factorHomo sapiens (human)
nucleusNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrionNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial intermembrane spaceNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial matrixNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
cytosolNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
mitochondrial matrixNAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID1337337Cytotoxicity against MDCK cells measured after 48 hrs by alamar blue assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors.
AID1436859Inhibition of LPS-induced tissue factor procoagulant activity in human THP1 cells preincubated for 1 hr followed by LPS addition measured after 5 hrs using factor 10a chromogenic substrate in presence of prothrombin complex2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity.
AID290240Enhancement of ConA-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 10 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1868241Inhibition of SENP1 in human SK-OV-3 cells assessed as increase in SUMOlytated JAK2 level at 5 uM after 48 hrs by immunoprecipitation method2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1868245Reversal of platinum resistance in cisplatin-resistant human SK-OV-3 cells assessed as reduction in cisplatin IC50 after 48 hrs in presence of cisplatin by SRB assay (Rvb = 28.23 microM)2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID290247Enhancement of LPS-Stimulated of lymphocyte proliferation in BALB/c mouse at 100 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1337338Selectivity index, ratio of CC50 for MDCK cells to IC50 for HCV pseudoparticle expressing envelope protein E1 and E2 to2016European journal of medicinal chemistry, Nov-29, Volume: 124Synthesis and biological evaluation of novel pentacyclic triterpene α-cyclodextrin conjugates as HCV entry inhibitors.
AID1446877Antiviral activity against HCV pseudoparticle harboring HCV envelope protein E1 and E2 assessed as inhibition of pseudoparticle entry into human Huh7 cells at 1 uM measured after 3 days by Bright-Glo luciferase reporter gene assay relative to control2017European journal of medicinal chemistry, Apr-21, Volume: 130Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors.
AID290249Enhancement of LPS-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 100 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1706906Inhibition of Ebola virus pseudoparticle GP HR2 domain-mediated viral entry into human 293T cells at 1 uM incubated for 72 hrs by Bright-Glo reagent based assay relative to control2020Journal of medicinal chemistry, 12-24, Volume: 63, Issue:24
Triterpenoid-Mediated Inhibition of Virus-Host Interaction: Is Now the Time for Discovering Viral Entry/Release Inhibitors from Nature?
AID290238Immunostimulatory effect against SRBC-inducing plaque forming cells in BALB/c mouse assessed as antibody secreting B cells at 10 mg/kg, po relative to control2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID290239Enhancement of ConA-Stimulated lymphocyte proliferation in BALB/c mouse at 10 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1728767Anti-necroptotic activity in mouse L929 cells assessed as inhibition of TNFalpha/Z-VAD-fmk (TZ)-induced necroptosis by measuring increase in cell viability measured after 12 hrs by celltiter-glo luminescent cell viability assay2021European journal of medicinal chemistry, Feb-15, Volume: 212Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
AID290244Enhancement of ConA-Stimulated lymphocyte proliferation in BALB/c mouse at 100 mg/kg by MTT assay2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1873015Inhibition of SIRT5 (unknown origin)2022European journal of medicinal chemistry, Jun-05, Volume: 236Overview of SIRT5 as a potential therapeutic target: Structure, function and inhibitors.
AID1868242Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability at 25 uM incubated for 48 hrs by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1446882Antiviral activity against HCV pseudoparticle harboring HCV envelope protein E1 and E2 assessed as inhibition of pseudoparticle entry into human Huh7 cells at 5 uM measured after 3 days by Bright-Glo luciferase reporter gene assay relative to control2017European journal of medicinal chemistry, Apr-21, Volume: 130Design, synthesis and biological evaluation of gentiopicroside derivatives as potential antiviral inhibitors.
AID290241Increased phagocytic index in BALB/c mouse at 10 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID290243Immunostimulatory effect against SRBC-inducing plaque forming cells in BALB/c mouse assessed as antibody secreting B cells at 100 mg/kg, po relative to control2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID290245Enhancement of ConA-stimulated blastogenic responsiveness in BALB/c mouse splenocytes at 100 mg/kg2007Bioorganic & medicinal chemistry letters, Mar-15, Volume: 17, Issue:6
Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice.
AID1868243Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1728762Anti-necroptotic activity in human HT-29 cells assessed as inhibition of TNFalpha/SM-164/Z-VAD-fmk (TSZ)-induced necroptosis by measuring increase in cell viability measured after 12 hrs by celltiter-glo luminescent cell viability assay2021European journal of medicinal chemistry, Feb-15, Volume: 212Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
AID1488673Hepatoprotective activity against APAP-induced cell injury in human HL-7702 cells assessed as increase in survival rate at 10 uM pre-incubated for 24 hrs before APAP addition and measured 6 hrs post APAP challenge by MTT assay2017Bioorganic & medicinal chemistry letters, 08-15, Volume: 27, Issue:16
Discovery and structure-activity relationship of auriculatone: A potent hepatoprotective agent against acetaminophen-induced liver injury.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (52)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (1.92)18.7374
1990's3 (5.77)18.2507
2000's6 (11.54)29.6817
2010's34 (65.38)24.3611
2020's8 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.65 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index5.31 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials0 (0.00%)5.53%
Reviews3 (33.33%)6.00%
Reviews1 (2.27%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other6 (66.67%)84.16%
Other43 (97.73%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]